DarioHealth Corp. (DRIO): Cost of Revenue
$9.69M
Year ended 2025-12-31
$8.79M
Trailing 12 months to 2026-06-30
-18.6%
3-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.69M | -29.6% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $13.77M | -4.1% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $14.37M | -20.2% | 2025-03-10, From 2023-01-01 |
| 2022-12-31 | $18.00M | +8.8% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $16.55M | n/c | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | $5.06M | +2.0% | 2022-03-22, From 2020-01-01 |
| 2019-12-31 | $4.96M | -11.8% | 2021-03-09, From 2019-01-01 |
| 2018-12-31 | $5.63M | +45.9% | 2020-03-17, From 2018-01-01 |
| 2017-12-31 | $3.86M | +14.7% | 2019-03-25, From 2017-01-01 |
| 2016-12-31 | $3.36M | +100.5% | 2018-03-19, From 2016-01-01 |
| 2015-12-31 | $1.68M | -26.2% | 2017-03-22, From 2015-01-01 |
| 2014-12-31 | $2.27M | n/a | 2016-02-08, From 2014-01-01 |
| 2013-12-31 | $0 | n/a | 2015-03-24, From 2013-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | 2025-12-31 | $9.69M | -29.6% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $3.65M | -16.7% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $10.72M | -34.2% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $12.11M | +37.3% |
| Nephros Inc (NEPH) | 2025-12-31 | $7.16M | +31.7% |
| Sensus Healthcare, Inc. (SRTS) | 2025-12-31 | $15.62M | -10.1% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $6.90M | +14.8% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $4.71M | +29.2% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $3.05M | -5.5% |
Compare DRIO, BDMD, MDAI, SNOA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗